These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33315137)

  • 1. [The first oral LHRH antagonist-results of the HERO study].
    Miller K
    Urologe A; 2021 Jan; 60(1):94-95. PubMed ID: 33315137
    [No Abstract]   [Full Text] [Related]  

  • 2. Recovery of Serum Testosterone Levels and Sexual Function in Patients Treated With Short-term Luteinizing Hormone-releasing Hormone Antagonist as a Neoadjuvant Therapy Before External Radiotherapy for Intermediate-risk Prostate Cancer: Preliminary Prospective Study.
    Inoue T; Mizowaki T; Kabata D; Shintani A; Terada N; Yamasaki T; Negoro H; Kobayashi T; Nakamura K; Inokuchi H; Ogawa O
    Clin Genitourin Cancer; 2018 Apr; 16(2):135-141.e1. PubMed ID: 29051056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropins and testosterone escape from suppression during prolonged luteinizing hormone-releasing hormone antagonist administration in normal men.
    Pavlou SN; Interlandi JW; Wakefield G; Island DP; Rivier J; Vale W; Kovacs WJ
    J Clin Endocrinol Metab; 1987 May; 64(5):1070-4. PubMed ID: 3104387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compensatory response of the luteinizing-hormone (LH)-releasing hormone (LHRH)/LH pulse generator after administration of a potent LHRH antagonist in the ram.
    Lincoln GA; Fraser HM
    Endocrinology; 1987 Jun; 120(6):2245-50. PubMed ID: 3032581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
    Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ
    J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does oral antiandrogen use before leuteinizing hormone-releasing hormone therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare?
    Oh WK; Landrum MB; Lamont EB; McNeil BJ; Keating NL
    Urology; 2010 Mar; 75(3):642-7. PubMed ID: 19962733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Testosterone Flare in the Era of the Saturation Model: One More Historical Myth.
    Krakowsky Y; Morgentaler A
    Eur Urol Focus; 2019 Jan; 5(1):81-89. PubMed ID: 28753828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men.
    Pavlou SN; Debold CR; Island DP; Wakefield G; Rivier J; Vale W; Rabin D
    J Clin Endocrinol Metab; 1986 Aug; 63(2):303-8. PubMed ID: 3088019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of luteinizing hormone-releasing hormone in adult male rhesus monkeys.
    Burgos-Briceño LA; Schally AV; Bartke A; Asch RH
    J Clin Endocrinol Metab; 1984 Oct; 59(4):601-7. PubMed ID: 6384248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of LHRH antagonists in the treatment of prostate cancer.
    Crawford ED; Hou AH
    Oncology (Williston Park); 2009 Jun; 23(7):626-30. PubMed ID: 19626830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone and estradiol potentiate the serum gonadotropin response to gonadotropin-releasing hormone in goldfish.
    Trudeau VL; Peter RE; Sloley BD
    Biol Reprod; 1991 Jun; 44(6):951-60. PubMed ID: 1873395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective determination of the hormonal response after cessation of luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.
    Hall MC; Fritzsch RJ; Sagalowsky AI; Ahrens A; Petty B; Roehrborn CG
    Urology; 1999 May; 53(5):898-902; discussion 902-3. PubMed ID: 10223480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of castration and testosterone replacement on basal and LHRH-stimulated cAMP and cGMP accumulation and on gonadotropin release from the pituitary of the male rat.
    Naor Z; Fawcett CP; McCann SM
    Mol Cell Endocrinol; 1979 Jun; 14(3):191-8. PubMed ID: 223902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influences of castration and testosterone on spring to summer changes in release of luteinizing-hormone-releasing hormone in rabbits.
    Lin WW; Ramirez VD
    J Reprod Fertil; 1992 Sep; 96(1):1-11. PubMed ID: 1432940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield GB; Island DP; Hoffman PG; LePage ME; Chan RL; Nerenberg CA; Kovacs WJ
    J Clin Endocrinol Metab; 1987 May; 64(5):931-6. PubMed ID: 3104388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of gonadectomy and testosterone replacement on thymic luteinizing hormone-releasing hormone production.
    Azad N; LaPaglia N; Agrawal L; Steiner J; Uddin S; Williams DW; Lawrence AM; Emanuele NV
    J Endocrinol; 1998 Aug; 158(2):229-35. PubMed ID: 9771467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteinizing hormone-releasing hormone does not inhibit testosterone production in rat interstitial cells in vitro.
    Badger TM; Beitins IZ; Ostrea T; Crisafulli JM; Little R; Saidel ME
    Endocrinology; 1980 Apr; 106(4):1149-53. PubMed ID: 6987051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.